indicated that anti-SORT1 could inhibit SORT1 to increase the level of PGRN in the cerebrospinal fluid, which is beneficial to the prognosis of frontotemporal dementia (FTD) (49). The gene discussed is GRN; the disease is frontotemporal dementia.